Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications

BACKGROUND: Molecular cancer classifier assays are being used with increasing frequency to predict tissue of origin and direct site-specific therapy for patients with carcinoma of unknown primary site (CUP). OBJECTIVE: We postulated some CUP patients predicted to have non-small-cell lung cancer (NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hainsworth, John D., Anthony Greco, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819469/
https://www.ncbi.nlm.nih.gov/pubmed/27747807
http://dx.doi.org/10.1007/s40801-016-0064-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819469/
https://www.ncbi.nlm.nih.gov/pubmed/27747807
http://dx.doi.org/10.1007/s40801-016-0064-7

Ejemplares similares